Keywords: Swedish Orphan Biovitrum SOBI, PharmaSwiss, European distribution, Megace, Monopril, Cefzil, Duricef

SOBI gains distribution rights for Megace, Monopril, Cefzil and Duricef from PharmaSwiss

Article | 13 February 2013

Print This

Swedish Orphan Biovitrum (STO: SOBI) says that it has entered into a distribution agreement with privately-held PharmaSwiss to market four ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in